220 related articles for article (PubMed ID: 12553106)
1. [Guillain-Barre syndrome and Campylobacter].
Engberg JH
Ugeskr Laeger; 2002 Dec; 164(50):5905-8. PubMed ID: 12553106
[No Abstract] [Full Text] [Related]
2. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
Hye JB; Nachamkin I
Neurology; 2007 May; 68(19):1633-4. PubMed ID: 17485654
[No Abstract] [Full Text] [Related]
3. A way out of the maze: Campylobacter jejuni gene polymorphisms define Guillain-Barré syndrome.
Wokke JH; van den Berg LH
Neurology; 2005 Nov; 65(9):1350-1. PubMed ID: 16275819
[No Abstract] [Full Text] [Related]
4. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barré syndrome?
Berciano J; Illa I
Neurology; 2005 Feb; 64(4):766-7; author reply 766-7. PubMed ID: 15728323
[No Abstract] [Full Text] [Related]
5. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
6. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome].
Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S
Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750
[TBL] [Abstract][Full Text] [Related]
7. Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.
Jacobs BC; Koga M; van Rijs W; Geleijns K; van Doorn PA; Willison HJ; Yuki N
J Neuroimmunol; 2008 Feb; 194(1-2):181-90. PubMed ID: 18178257
[TBL] [Abstract][Full Text] [Related]
8. Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?
Yuki N; Koga M; Hirata K
Acta Neurol Scand; 2000 Aug; 102(2):132-4. PubMed ID: 10949532
[TBL] [Abstract][Full Text] [Related]
9. Utility of serum Campylobacter specific antibodies in determining prior Campylobacter infection in neurological disease.
Taylor BV; Williamson J; Jones D; Coleman D; Luck J; McGregor A
J Clin Neurosci; 2007 Feb; 14(2):116-21. PubMed ID: 17107803
[TBL] [Abstract][Full Text] [Related]
10. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
Koga M; Yuki N
Neurology; 2007 Oct; 69(17):1727-8; author reply 1728. PubMed ID: 17954791
[No Abstract] [Full Text] [Related]
11. Investigation of possible cytokine induction in peripheral blood mononuclear cells by heat-stable serotypes of Campylobacter jejuni.
Chatzipanagiotou S; Michalopoulou M; Marinou I; Boufidou F; Papavasileiou E; Trikka-Graphakos E; Kabouri E; Nicolaou C; Legakis NJ
Clin Microbiol Infect; 2005 Jan; 11(1):63-5. PubMed ID: 15649306
[TBL] [Abstract][Full Text] [Related]
12. Campylobacter jejuni and Guillain-Barré syndrome.
Rees JH; Hughes RA
Ann Neurol; 1994 Feb; 35(2):248-9. PubMed ID: 8109911
[No Abstract] [Full Text] [Related]
13. The relationship of Campylobacter jejuni infection and the development of Guillain-Barré syndrome.
Tsang RS
Curr Opin Infect Dis; 2002 Jun; 15(3):221-8. PubMed ID: 12015454
[TBL] [Abstract][Full Text] [Related]
14. A family with Campylobacter enteritis: anti-GD1a antibody with/without Guillain-Barré syndrome.
Hirano M; Kusunoki S; Asai H; Tonomura Y; Morita D; Ueno S
Neurology; 2003 May; 60(10):1719-20. PubMed ID: 12771281
[No Abstract] [Full Text] [Related]
15. Association of Campylobacter jejuni infection and GuillainBarré syndrome: a cohort study in the northwest of Iran.
Barzegar M; Alizadeh A; Toopchizadeh V; Dastgiri S; Majidi J
Turk J Pediatr; 2008; 50(5):443-8. PubMed ID: 19102048
[TBL] [Abstract][Full Text] [Related]
16. [Campylobacter jejuni infection in patient with Guillain-Barré syndrome: a case report].
Kopyta I; Wardak S
Med Dosw Mikrobiol; 2008; 60(1):59-63. PubMed ID: 18634345
[TBL] [Abstract][Full Text] [Related]
17. [Pathogenesis of axonal Guillain-Barré syndrome].
Yuki N
Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
[TBL] [Abstract][Full Text] [Related]
18. [A case-control study on Guillain-Barre syndrome in children of North China].
Wu Z; Wu H; Wang Q; Zhaori G; Wang C; Liang Z; Shan G; Cui S; Pan L; Zheng J; Zuo Q; Zhang Y; Zhang K
Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Sep; 33(5):279-81. PubMed ID: 11864491
[TBL] [Abstract][Full Text] [Related]
19. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.
Schmidt-Ott R; Schmidt H; Feldmann S; Brass F; Krone B; Gross U
Clin Vaccine Immunol; 2006 Jul; 13(7):779-83. PubMed ID: 16829615
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
